-
1 Comment
Nephros, Inc is currently in a long term uptrend where the price is trading 13.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.5.
Nephros, Inc's total revenue sank by 26.2% to $2M since the same quarter in the previous year.
Its net income has dropped by 300.0% to $-820K since the same quarter in the previous year.
Finally, its free cash flow fell by 536.0% to $-2M since the same quarter in the previous year.
Based on the above factors, Nephros, Inc gets an overall score of 2/5.
CurrencyCode | USD |
---|---|
ISIN | US6406714005 |
Exchange | NASDAQ |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Target Price | 4.75 |
---|---|
Beta | 1.05 |
Market Cap | 20M |
PE Ratio | 186.0 |
Dividend Yield | None |
Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. It also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, bacteria, cysts, particulates, heavy metals, chemical compounds, scale build-up in downstream equipment, and other various contaminants. It provides medical device products such as the DSU-H and SSU-H which are in-line, 0.005-micron ultrafilters that give dual- and single-stage protection, respectively; S100 which is a point-of-use, 0.01-micron microfilter; and the HydraGuard and HydraGuard - Flush which are 0.005-micron cartridge ultrafilters that given single-stage protection, these products give protection from waterborne pathogens. Further, it provides the DSU-D, SSU-D, and SSUmini are in-line, 0.005-micron ultrafilters that provide protection from bacteria, viruses, and endotoxins; and the EndoPur, a 0.005-micron cartridge ultrafilter that provides single-stage protection from bacteria, viruses, and endotoxins. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for NEPH using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025